Lupin Receives USFDA Approval for Dapagliflozin + Metformin Combination Tablets 08/04/2026 / Material Events / Regulatory Approval Update Lupin Receives USFDA Approval for Dapagliflozin + Metformin Combination Tablets Read Post »
Zydus Receives USFDA Approval for Dapagliflozin Tablets with 180-Day Exclusivity 08/04/2026 / Material Events / Regulatory Approval Update Zydus Receives USFDA Approval for Dapagliflozin Tablets with 180-Day Exclusivity Read Post »
Biocon Pharma Receives USFDA Approval for Dapagliflozin Tablets 08/04/2026 / Material Events / Regulatory Approval Update Biocon Pharma Receives USFDA Approval for Dapagliflozin Tablets Read Post »
Alembic Pharma Receives USFDA Final Approval for Dapagliflozin Tablets 07/04/2026 / Material Events / Regulatory Approval Update Alembic Pharma Receives USFDA Final Approval for Dapagliflozin Tablets Read Post »
GE Power India Receives ‘No Objection’ from NSE & ‘No Adverse Observations’ from BSE for Scheme with JSW Energy 02/04/2026 / Regulatory Filings / Regulatory Approval Update GE Power India Receives ‘No Objection’ from NSE & ‘No Adverse Observations’ from BSE for Scheme with JSW Energy Read Post »
